• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素受体及胰岛素受体底物基因多态性与多囊卵巢综合征的关联:一项系统评价与荟萃分析

Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis.

作者信息

Shi Xiaohan, Xie Xiaochuan, Jia Yingxian, Li Shangwei

机构信息

Division of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, China.

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

J Obstet Gynaecol Res. 2016 Jul;42(7):844-54. doi: 10.1111/jog.13002. Epub 2016 Apr 20.

DOI:10.1111/jog.13002
PMID:27098445
Abstract

AIM

Recently, the roles of insulin receptor (INSR) and insulin receptor substrate (IRS) polymorphisms in polycystic ovary syndrome (PCOS) have been extensively studied, with conflicting results. Therefore, we conducted the present systematic review and meta-analysis to better evaluate associations of INSR and IRS polymorphisms with PCOS.

METHODS

We searched PubMed, Medline, EMBASE, Google Scholar and China National Knowledge Infrastructure for eligible articles up to December 2015. Odds ratios (OR) and 95% confidence intervals (CI) were used to evaluate associations of INSR and IRS polymorphisms with PCOS.

RESULTS

A total of 28 articles including 2975 PCOS patients and 3011 control subjects were analyzed. The overall analyses and subgroup analyses revealed that IRS-1 Gly972Arg polymorphism was significantly associated with PCOS for the Caucasian population in GG versus GA (OR = 0.57, 95%CI 0.37-0.89), GG versus GA + AA (OR = 0.57, 95%CI 0.36-0.89), GA versus GG + AA (OR = 1.74, 95%CI 1.13-2.69) and G versus A (OR = 0.63 95%CI 0.43-0.92). Also, IRS-2 Gly1057Asp polymorphism was significantly associated with PCOS for the Asian ethnicity in GG versus GA (OR = 0.45, 95%CI 0.24-0.83), GG versus AA (OR = 0.32, 95%CI 0.19-0.53), GG versus GA + AA (OR = 0.35, 95%CI 0.21-0.57), AA versus GG + GA (OR = 2.14, 95%CI 1.43-3.20), and G versus A (OR = 0.43, 95%CI 0.32-0.58). However, we detected no significant association between INSR His 1058 C/T polymorphism and PCOS.

CONCLUSION

Our findings suggest that IRS-1 Gly972Arg polymorphism is associated with PCOS in the Caucasian ethnicity, and IRS-2 Gly1057Asp polymorphism is correlated with PCOS in the Asian ethnicity. However, INSR His 1058 C/T polymorphism may not be implicated in PCOS. © 2016 Japan Society of Obstetrics and Gynecology.

摘要

目的

近年来,胰岛素受体(INSR)和胰岛素受体底物(IRS)基因多态性在多囊卵巢综合征(PCOS)中的作用已得到广泛研究,但结果相互矛盾。因此,我们进行了本系统评价和荟萃分析,以更好地评估INSR和IRS基因多态性与PCOS的关联。

方法

我们检索了截至2015年12月的PubMed、Medline、EMBASE、谷歌学术和中国知网,以查找符合条件的文章。采用比值比(OR)和95%置信区间(CI)来评估INSR和IRS基因多态性与PCOS的关联。

结果

共分析了28篇文章,包括2975例PCOS患者和3011例对照受试者。总体分析和亚组分析显示,对于白种人群,IRS-1 Gly972Arg基因多态性在GG与GA比较时(OR = 0.57,95%CI 0.37 - 0.89)、GG与GA + AA比较时(OR = 0.57,95%CI 0.36 - 0.89)、GA与GG + AA比较时(OR = 1.74,95%CI 1.13 - 2.69)以及G与A比较时(OR = 0.63,95%CI 0.43 - 0.92)与PCOS显著相关。此外,对于亚洲人种,IRS-2 Gly1057Asp基因多态性在GG与GA比较时(OR = 0.45,95%CI 0.24 - 0.83)、GG与AA比较时(OR = 0.32,95%CI 0.19 - 0.53)、GG与GA + AA比较时(OR = 0.35,95%CI 0.21 - 0.57)、AA与GG + GA比较时(OR = 2.14,95%CI 1.43 - 3.20)以及G与A比较时(OR = 0.43,95%CI 0.32 - 0.58)与PCOS显著相关。然而,我们未检测到INSR His 1058 C/T基因多态性与PCOS之间存在显著关联。

结论

我们的研究结果表明,IRS-1 Gly972Arg基因多态性与白种人PCOS相关,IRS-2 Gly1057Asp基因多态性与亚洲人种PCOS相关。然而,INSR His 1058 C/T基因多态性可能与PCOS无关。© 2016日本妇产科学会。

相似文献

1
Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis.胰岛素受体及胰岛素受体底物基因多态性与多囊卵巢综合征的关联:一项系统评价与荟萃分析
J Obstet Gynaecol Res. 2016 Jul;42(7):844-54. doi: 10.1111/jog.13002. Epub 2016 Apr 20.
2
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
3
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中中度和重度抑郁及焦虑症状的高患病率:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044.
4
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.用于多囊卵巢综合征不孕女性的中草药
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3.
5
Association between fat mass and obesity associated (FTO) gene rs9939609 A/T polymorphism and polycystic ovary syndrome: a systematic review and meta-analysis.脂肪量与肥胖相关(FTO)基因rs9939609 A/T多态性与多囊卵巢综合征的关联:一项系统评价和荟萃分析。
BMC Med Genet. 2017 Aug 21;18(1):89. doi: 10.1186/s12881-017-0452-1.
6
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.多囊卵巢综合征女性的卵巢手术以缓解症状
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2.
7
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.二甲双胍是否能改善非肥胖型多囊卵巢综合征不孕妇女的生殖结局?荟萃分析和系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1.
8
Lack of association between aryl hydrocarbon receptor gene Arg554Lys polymorphism and male infertility risk: A systematic review and meta-analysis.芳烃受体基因Arg554Lys多态性与男性不育风险之间缺乏关联:一项系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:1-7. doi: 10.1016/j.ejogrb.2018.01.032. Epub 2018 Jan 31.
9
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)用于多囊卵巢综合征的不孕女性。
Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3.
10
Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.抗苗勒管激素(AMH Ile49Ser)及其II型受体(AMHRII -482 A>G)基因多态性与生殖结局及多囊卵巢综合征的关联:一项系统评价和荟萃分析
Cell Physiol Biochem. 2016;39(6):2249-2261. doi: 10.1159/000447918. Epub 2016 Nov 7.

引用本文的文献

1
Custom exome panel revealed new mutations in MAPK14 and novel mutation in RUNX2 gene in patients with PCOS.定制外显子组检测揭示了多囊卵巢综合征患者中MAPK14基因的新突变以及RUNX2基因的新突变。
Sci Rep. 2025 Jan 16;15(1):2128. doi: 10.1038/s41598-024-81969-9.
2
Association of Gene Polymorphisms with Polycystic Ovary Syndrome: A Meta-analysis.基因多态性与多囊卵巢综合征的关联:一项荟萃分析。
Gynecol Minim Invasive Ther. 2024 Sep 6;13(4):232-240. doi: 10.4103/gmit.gmit_106_23. eCollection 2024 Oct-Dec.
3
Association of candidate gene () polymorphism with polycystic ovary syndrome: meta-analysis and statistical power analysis.
候选基因()多态性与多囊卵巢综合征的关联:荟萃分析和统计效能分析。
J Turk Ger Gynecol Assoc. 2024 Aug 29;25(3):167-178. doi: 10.4274/jtgga.galenos.2024.2024-1-7.
4
Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome.胰岛素受体底物 1 甘氨酸 972 精氨酸(rs1801278)多态性与克什米尔多囊卵巢综合征妇女的肥胖和胰岛素抵抗有关。
Genes (Basel). 2022 Aug 17;13(8):1463. doi: 10.3390/genes13081463.
5
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.多囊卵巢综合征的最新进展:诊断、遗传病因学和新兴治疗选择的现有知识综述。
Womens Health (Lond). 2022 Jan-Dec;18:17455057221117966. doi: 10.1177/17455057221117966.
6
The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides.胰岛素受体:新型药物和农药开发的重要靶标。
Int J Mol Sci. 2022 Jul 14;23(14):7793. doi: 10.3390/ijms23147793.
7
Single nucleotide polymorphisms in binding site of miRNA-135a and targeted gene IRS2 are correlated with multiple clinical features of PCOS: A study in Chinese women.miRNA-135a 结合位点单核苷酸多态性与 IRS2 靶向基因与 PCOS 的多种临床特征相关:中国女性的研究。
Technol Health Care. 2022;30(S1):71-80. doi: 10.3233/THC-228007.
8
Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?多囊卵巢综合征与桥本甲状腺炎同时发生的遗传易感性:我们的理解有多深?
Front Immunol. 2021 Feb 26;12:606620. doi: 10.3389/fimmu.2021.606620. eCollection 2021.
9
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review.通过D-手性肌醇和新兴营养保健品靶向多囊卵巢综合征胰岛素抵抗的代谢后果:一项重点综述
J Clin Med. 2020 Apr 2;9(4):987. doi: 10.3390/jcm9040987.
10
Effects of FSHR polymorphisms on premature ovarian insufficiency in human beings: a meta-analysis.促卵泡激素受体基因多态性对人类卵巢早衰的影响:一项荟萃分析。
Reprod Biol Endocrinol. 2019 Oct 19;17(1):80. doi: 10.1186/s12958-019-0528-1.